(MENAFN- Verified Market Research) 'Global Bioidentical Hormones Market By End User (Hospital, Clinics, Others), By Type (Estrogens, Progesterone, Testosterone, Others), By Product Type (Tablets & Capsules, Creams & Gels, Injectable, Patches & Implants, Others) and Region- Global Market Size, Status and Forecast to 2026″, published by Verified Market Research.
The Global Bioidentical Hormones Market size is projected to grow from USD 6.63 Billion in 2018 to USD 9.92 Billion by 2026, at a CAGR of 5.26% from 2019 to 2026. Rising health awareness among female population is expected to support market growth during the forecast period.
Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=31939&utm_source=Free&utm_medium=004#downlaod-report
Browse in-depth TOC on 'Global Bioidentical Hormones Market'
74 – Tables
39 – Figures
107 – Pages
In terms of End User, the hospitals segment is estimated to be the fastest-growing type in the Global Bioidentical Hormones market during forecast period.
By product type, the market is classified into Tablets & Capsules, Creams & Gels, Injectable, Patches & Implants, and Others. Global Bioidentical Hormones Market for Tablets & Capsules segment is expected to be largest till 2026. Tablets & capsules hold the largest market share in the global bioidentical hormone market in 2018 and continue to hold the largest revenue share during the forecast period. This share can be attributed to factors such as high consumption of bioidentical hormone capsule and higher availability tablets & capsule products in the market. For instance, there are many FDA approved tablets and capsules including Ethinyl estradiol, conjugated equine estrogen, norethindrone acetate, norgestrel, desogestrel, methyltestosterone.
In addition to this, Estrogen holds the major share of the type of the market. The estrogen hormone is involved in the reproduction system of both female and male, and several other biological systems such as vascular, neuroendocrine, immune, and skeletal systems. Hence, it is also associated with several different conditions such as obesity, infertility, endometriosis, osteoporosis, and a range of cancers including breast cancer. Estrogen functions over its two separate nuclear receptors including estrogen receptor alpha and estrogen receptor beta.
Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=31939&utm_source=Free&utm_medium=004#downlaod-report
The North America region is projected to account for the largest share in the Global Bioidentical Hormones market during the forecast period from 2019 to 2026.
Organizations that are working towards forming guidelines on the use of hormone therapy (HT) and bioidentical hormone therapy (BHT) are the Endocrine Society, the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists. Prominent vendors in North America are launching new products to increase their market share, which is strengthening the regional market share. For instance, in November 2018, Noven unveiled the estradiol transdermal system in the United States.
Key players
Noven Pharmaceuticals, Novartis AG, Sottepolle , BioTE Medical , Pfizer Inc., TherapeuticsMD Inc, Bayer AG , Novo Nordisk A/S , Allergan , and Merck KGaA are the key players operating in the Global Bioidentical Hormones market. Partnerships, acquisitions and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Global Bioidentical Hormones Market.
Obtain Report Details @ https://www.verifiedmarketresearch.com/press-release/bioidentical-hormones-market/?utm_source=Free&utm_medium=004
MENAFN02042020007010837ID1099957895
-MENAFN02042020007010837ID1099957895-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.